The prevention of minor myocardial injury with ticlopidine pretreatment in patients undergoing elective coronary stenting
The aim of the study was to determine whether ticlopidine treatment prior the coronary stenting would be associated with lower rates of procedure-related minor myocardial injury (MMI) in patients undergoing elective coronary stenting. In this retrospective, nonrandomized, uncontrolled study, a total...
Gespeichert in:
| Veröffentlicht in: | International journal of cardiology 2003-02, Vol.87 (2), p.151-157 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 157 |
|---|---|
| container_issue | 2 |
| container_start_page | 151 |
| container_title | International journal of cardiology |
| container_volume | 87 |
| creator | Atmaca, Yusuf Gülec, Sadi Ertas, Fatih Pamir, Gülgün Oral, Dervis |
| description | The aim of the study was to determine whether ticlopidine treatment prior the coronary stenting would be associated with lower rates of procedure-related minor myocardial injury (MMI) in patients undergoing elective coronary stenting. In this retrospective, nonrandomized, uncontrolled study, a total of 153 consecutive patients with a mean age of 63.4±8.9 years were divided into two groups based on the duration of ticlopidine treatment: group I (
n=81), ticlopidine ≥3 days before the procedure, group II (
n=72), on the same day as stent placement. Cardiac troponin T (cTnT) was measured immediately before and 12 h after the procedures. All patients were followed-up during the hospital stay with respect to MMI and major clinical events (MCE). The increase frequency and the amount of cTnT level in group I was found to be significantly lower compared with group II (4 vs. 13;
P |
| doi_str_mv | 10.1016/S0167-5273(02)00315-7 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72993827</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0167527302003157</els_id><sourcerecordid>72993827</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-a95873ab3c4061ede3545c563e7471e1dc0d82b31d8583641a9f2573fc8c69e33</originalsourceid><addsrcrecordid>eNqFkE1v1DAQhi1ERZeFnwDyBQSHgB3bcXxCqAJaqVIPlLPltSdbV4kdbGfR_nu8H6JHLjNzeN6Z0YPQG0o-UUK7zz9rkY1oJftA2o-EMCoa-QytaC95Q6Xgz9HqH3KJXub8SAjhSvUv0CVthVCC8RXa3z8AnhPsIBQfA44DnnyICU_7aE1y3ozYh8cl7fEfXx5w8XaMs3c-HGMlgSlTzVYIz6b4Oma8BAdpG33YYhjBFr8DbGOKwdQ1uRxOhe0rdDGYMcPrc1-jX9-_3V9dN7d3P26uvt42lilaGqNEL5nZMMtJR8EBE1xY0TGQXFKgzhLXtxtGXS961nFq1NAKyQbb204BY2v0_rR3TvH3ArnoyWcL42gCxCVr2SrF-ippjcQJtCnmnGDQc_JTfVlTog_O9dG5PgjVpNVH5_qQe3s-sGwmcE-ps-QKvDsDJlszDskE6_MTxwXpOiYq9-XEQdWx85B0tlWoBedTtahd9P955S8_S6Cz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72993827</pqid></control><display><type>article</type><title>The prevention of minor myocardial injury with ticlopidine pretreatment in patients undergoing elective coronary stenting</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Atmaca, Yusuf ; Gülec, Sadi ; Ertas, Fatih ; Pamir, Gülgün ; Oral, Dervis</creator><creatorcontrib>Atmaca, Yusuf ; Gülec, Sadi ; Ertas, Fatih ; Pamir, Gülgün ; Oral, Dervis</creatorcontrib><description>The aim of the study was to determine whether ticlopidine treatment prior the coronary stenting would be associated with lower rates of procedure-related minor myocardial injury (MMI) in patients undergoing elective coronary stenting. In this retrospective, nonrandomized, uncontrolled study, a total of 153 consecutive patients with a mean age of 63.4±8.9 years were divided into two groups based on the duration of ticlopidine treatment: group I (
n=81), ticlopidine ≥3 days before the procedure, group II (
n=72), on the same day as stent placement. Cardiac troponin T (cTnT) was measured immediately before and 12 h after the procedures. All patients were followed-up during the hospital stay with respect to MMI and major clinical events (MCE). The increase frequency and the amount of cTnT level in group I was found to be significantly lower compared with group II (4 vs. 13;
P<0.01, and 0.35±0.06 vs. 0.52±0.11 ng/ml;
P<0.01, respectively). In general, patients with elevated cTnT levels are more likely to have C type lesion and multivessel procedure than those of normal cTnT level (41 vs.10%;
P<0.002 and 47 vs. 17%;
P<0.009, respectively). Though there was a trend toward increased MCE rates in group II than that of group I, this did not reached statistical significance (3 vs.1;
P=NS). The present study shows that an anti-platelet treatment with ticlopidine prior the coronary stenting of adequate duration to allow for the development of maximal inhibition is associated with a markedly decreased incidence of procedure-related MMI. Therefore, ticlopidine pretreatment may be a cost alternative for the prevention of platelet-rich microembolism in patients undergoing elective coronary stenting.</description><identifier>ISSN: 0167-5273</identifier><identifier>EISSN: 1874-1754</identifier><identifier>DOI: 10.1016/S0167-5273(02)00315-7</identifier><identifier>PMID: 12559534</identifier><identifier>CODEN: IJCDD5</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Aged ; Angioplasty, Balloon, Coronary - adverse effects ; Angioplasty, Balloon, Coronary - methods ; Biological and medical sciences ; Chi-Square Distribution ; Coronary Disease - diagnosis ; Coronary Disease - therapy ; Diseases of the cardiovascular system ; Female ; Follow-Up Studies ; Humans ; Male ; Medical sciences ; Middle Aged ; Minor myocardial injury ; Myocardial Reperfusion Injury - prevention & control ; Primary Prevention - methods ; Probability ; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) ; Retrospective Studies ; Risk Assessment ; Stent ; Stents - adverse effects ; Ticlopidine ; Ticlopidine - administration & dosage ; Treatment Outcome</subject><ispartof>International journal of cardiology, 2003-02, Vol.87 (2), p.151-157</ispartof><rights>2002 Elsevier Science Ireland Ltd</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-a95873ab3c4061ede3545c563e7471e1dc0d82b31d8583641a9f2573fc8c69e33</citedby><cites>FETCH-LOGICAL-c391t-a95873ab3c4061ede3545c563e7471e1dc0d82b31d8583641a9f2573fc8c69e33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0167-5273(02)00315-7$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14506635$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12559534$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Atmaca, Yusuf</creatorcontrib><creatorcontrib>Gülec, Sadi</creatorcontrib><creatorcontrib>Ertas, Fatih</creatorcontrib><creatorcontrib>Pamir, Gülgün</creatorcontrib><creatorcontrib>Oral, Dervis</creatorcontrib><title>The prevention of minor myocardial injury with ticlopidine pretreatment in patients undergoing elective coronary stenting</title><title>International journal of cardiology</title><addtitle>Int J Cardiol</addtitle><description>The aim of the study was to determine whether ticlopidine treatment prior the coronary stenting would be associated with lower rates of procedure-related minor myocardial injury (MMI) in patients undergoing elective coronary stenting. In this retrospective, nonrandomized, uncontrolled study, a total of 153 consecutive patients with a mean age of 63.4±8.9 years were divided into two groups based on the duration of ticlopidine treatment: group I (
n=81), ticlopidine ≥3 days before the procedure, group II (
n=72), on the same day as stent placement. Cardiac troponin T (cTnT) was measured immediately before and 12 h after the procedures. All patients were followed-up during the hospital stay with respect to MMI and major clinical events (MCE). The increase frequency and the amount of cTnT level in group I was found to be significantly lower compared with group II (4 vs. 13;
P<0.01, and 0.35±0.06 vs. 0.52±0.11 ng/ml;
P<0.01, respectively). In general, patients with elevated cTnT levels are more likely to have C type lesion and multivessel procedure than those of normal cTnT level (41 vs.10%;
P<0.002 and 47 vs. 17%;
P<0.009, respectively). Though there was a trend toward increased MCE rates in group II than that of group I, this did not reached statistical significance (3 vs.1;
P=NS). The present study shows that an anti-platelet treatment with ticlopidine prior the coronary stenting of adequate duration to allow for the development of maximal inhibition is associated with a markedly decreased incidence of procedure-related MMI. Therefore, ticlopidine pretreatment may be a cost alternative for the prevention of platelet-rich microembolism in patients undergoing elective coronary stenting.</description><subject>Aged</subject><subject>Angioplasty, Balloon, Coronary - adverse effects</subject><subject>Angioplasty, Balloon, Coronary - methods</subject><subject>Biological and medical sciences</subject><subject>Chi-Square Distribution</subject><subject>Coronary Disease - diagnosis</subject><subject>Coronary Disease - therapy</subject><subject>Diseases of the cardiovascular system</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Minor myocardial injury</subject><subject>Myocardial Reperfusion Injury - prevention & control</subject><subject>Primary Prevention - methods</subject><subject>Probability</subject><subject>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Stent</subject><subject>Stents - adverse effects</subject><subject>Ticlopidine</subject><subject>Ticlopidine - administration & dosage</subject><subject>Treatment Outcome</subject><issn>0167-5273</issn><issn>1874-1754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1v1DAQhi1ERZeFnwDyBQSHgB3bcXxCqAJaqVIPlLPltSdbV4kdbGfR_nu8H6JHLjNzeN6Z0YPQG0o-UUK7zz9rkY1oJftA2o-EMCoa-QytaC95Q6Xgz9HqH3KJXub8SAjhSvUv0CVthVCC8RXa3z8AnhPsIBQfA44DnnyICU_7aE1y3ozYh8cl7fEfXx5w8XaMs3c-HGMlgSlTzVYIz6b4Oma8BAdpG33YYhjBFr8DbGOKwdQ1uRxOhe0rdDGYMcPrc1-jX9-_3V9dN7d3P26uvt42lilaGqNEL5nZMMtJR8EBE1xY0TGQXFKgzhLXtxtGXS961nFq1NAKyQbb204BY2v0_rR3TvH3ArnoyWcL42gCxCVr2SrF-ippjcQJtCnmnGDQc_JTfVlTog_O9dG5PgjVpNVH5_qQe3s-sGwmcE-ps-QKvDsDJlszDskE6_MTxwXpOiYq9-XEQdWx85B0tlWoBedTtahd9P955S8_S6Cz</recordid><startdate>20030201</startdate><enddate>20030201</enddate><creator>Atmaca, Yusuf</creator><creator>Gülec, Sadi</creator><creator>Ertas, Fatih</creator><creator>Pamir, Gülgün</creator><creator>Oral, Dervis</creator><general>Elsevier Ireland Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030201</creationdate><title>The prevention of minor myocardial injury with ticlopidine pretreatment in patients undergoing elective coronary stenting</title><author>Atmaca, Yusuf ; Gülec, Sadi ; Ertas, Fatih ; Pamir, Gülgün ; Oral, Dervis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-a95873ab3c4061ede3545c563e7471e1dc0d82b31d8583641a9f2573fc8c69e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Aged</topic><topic>Angioplasty, Balloon, Coronary - adverse effects</topic><topic>Angioplasty, Balloon, Coronary - methods</topic><topic>Biological and medical sciences</topic><topic>Chi-Square Distribution</topic><topic>Coronary Disease - diagnosis</topic><topic>Coronary Disease - therapy</topic><topic>Diseases of the cardiovascular system</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Minor myocardial injury</topic><topic>Myocardial Reperfusion Injury - prevention & control</topic><topic>Primary Prevention - methods</topic><topic>Probability</topic><topic>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Stent</topic><topic>Stents - adverse effects</topic><topic>Ticlopidine</topic><topic>Ticlopidine - administration & dosage</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Atmaca, Yusuf</creatorcontrib><creatorcontrib>Gülec, Sadi</creatorcontrib><creatorcontrib>Ertas, Fatih</creatorcontrib><creatorcontrib>Pamir, Gülgün</creatorcontrib><creatorcontrib>Oral, Dervis</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Atmaca, Yusuf</au><au>Gülec, Sadi</au><au>Ertas, Fatih</au><au>Pamir, Gülgün</au><au>Oral, Dervis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The prevention of minor myocardial injury with ticlopidine pretreatment in patients undergoing elective coronary stenting</atitle><jtitle>International journal of cardiology</jtitle><addtitle>Int J Cardiol</addtitle><date>2003-02-01</date><risdate>2003</risdate><volume>87</volume><issue>2</issue><spage>151</spage><epage>157</epage><pages>151-157</pages><issn>0167-5273</issn><eissn>1874-1754</eissn><coden>IJCDD5</coden><abstract>The aim of the study was to determine whether ticlopidine treatment prior the coronary stenting would be associated with lower rates of procedure-related minor myocardial injury (MMI) in patients undergoing elective coronary stenting. In this retrospective, nonrandomized, uncontrolled study, a total of 153 consecutive patients with a mean age of 63.4±8.9 years were divided into two groups based on the duration of ticlopidine treatment: group I (
n=81), ticlopidine ≥3 days before the procedure, group II (
n=72), on the same day as stent placement. Cardiac troponin T (cTnT) was measured immediately before and 12 h after the procedures. All patients were followed-up during the hospital stay with respect to MMI and major clinical events (MCE). The increase frequency and the amount of cTnT level in group I was found to be significantly lower compared with group II (4 vs. 13;
P<0.01, and 0.35±0.06 vs. 0.52±0.11 ng/ml;
P<0.01, respectively). In general, patients with elevated cTnT levels are more likely to have C type lesion and multivessel procedure than those of normal cTnT level (41 vs.10%;
P<0.002 and 47 vs. 17%;
P<0.009, respectively). Though there was a trend toward increased MCE rates in group II than that of group I, this did not reached statistical significance (3 vs.1;
P=NS). The present study shows that an anti-platelet treatment with ticlopidine prior the coronary stenting of adequate duration to allow for the development of maximal inhibition is associated with a markedly decreased incidence of procedure-related MMI. Therefore, ticlopidine pretreatment may be a cost alternative for the prevention of platelet-rich microembolism in patients undergoing elective coronary stenting.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>12559534</pmid><doi>10.1016/S0167-5273(02)00315-7</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0167-5273 |
| ispartof | International journal of cardiology, 2003-02, Vol.87 (2), p.151-157 |
| issn | 0167-5273 1874-1754 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72993827 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Aged Angioplasty, Balloon, Coronary - adverse effects Angioplasty, Balloon, Coronary - methods Biological and medical sciences Chi-Square Distribution Coronary Disease - diagnosis Coronary Disease - therapy Diseases of the cardiovascular system Female Follow-Up Studies Humans Male Medical sciences Middle Aged Minor myocardial injury Myocardial Reperfusion Injury - prevention & control Primary Prevention - methods Probability Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Retrospective Studies Risk Assessment Stent Stents - adverse effects Ticlopidine Ticlopidine - administration & dosage Treatment Outcome |
| title | The prevention of minor myocardial injury with ticlopidine pretreatment in patients undergoing elective coronary stenting |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T01%3A56%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20prevention%20of%20minor%20myocardial%20injury%20with%20ticlopidine%20pretreatment%20in%20patients%20undergoing%20elective%20coronary%20stenting&rft.jtitle=International%20journal%20of%20cardiology&rft.au=Atmaca,%20Yusuf&rft.date=2003-02-01&rft.volume=87&rft.issue=2&rft.spage=151&rft.epage=157&rft.pages=151-157&rft.issn=0167-5273&rft.eissn=1874-1754&rft.coden=IJCDD5&rft_id=info:doi/10.1016/S0167-5273(02)00315-7&rft_dat=%3Cproquest_cross%3E72993827%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72993827&rft_id=info:pmid/12559534&rft_els_id=S0167527302003157&rfr_iscdi=true |